Analytical Data
-
Gene name
AADACL2
- Application
-
Alternative Names
AADACL2Arylacetamide deacetylase-like 2; EC 3.1.1.-
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6P093
-
Expression Region
19-401aa
-
AA Sequence
FY TPMPDNIEES WKIMALDAIA KTCTFTAMCF ENMRIMRYEE FISMIFRLDY TQPLSDEYIT VTDTTFVDIP VRLYLPKRKS ETRRRAVIYF HGGGFCFGSS KQRAFDFLNR WTANTLDAVV VGVDYRLAPQ HHFPAQFEDG LAAVKFFLLE KILTKYGVDP TRICIAGDSS GGNLATAVTQ QVQNDAEIKH KIKMQVLLYP GLQITDSYLP SHRENEHGIV LTRDVAIKLV SLYFTKDEAL PWAMRRNQHM PLESRHLFKF VNWSILLPEK YRKDYVYTEP ILGGLSYSLP GLTDSRALPL LANDSQLQNL PLTYILTCQH DLLRDDGLMY VTRLRNVGVQ VVHEHIEDGI HGALSFMTSP FYLRLGLRIR DMYVSWLDKN L
-
Molecular Weight
46 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AADACL2 (Amino Acid Decarboxylase-Associated Protein 2) is a member of the serine hydrolase family that has garnered interest due to its potential involvement in various physiological processes and its implications in disease mechanisms. This protein is primarily expressed in the brain and other tissues, suggesting a significant role in central nervous system functions. Recent studies have indicated that AADACL2 may play a critical role in lipid metabolism and neuroprotection, making it a candidate for research in neurodegenerative diseases and metabolic disorders. Investigating the structural and functional properties of AADACL2, particularly in its recombinant form, can provide insights into its enzymatic activities and regulatory mechanisms. Furthermore, exploring the protein's interactions with other cellular components may elucidate its role in the pathophysiology of conditions such as Alzheimer’s disease and other forms of dementia. The successful expression and characterization of recombinant AADACL2 could facilitate the development of novel therapeutic strategies targeting its pathway, underscoring the importance of continued research in this area. Overall, the study of AADACL2 and the implications of its recombinant protein hold great promise for advancing our understanding of complex biological systems and their associated disorders.
